Scleroderma News and Research

RSS
Scleroderma is a chronic, often progressive, autoimmune disease in which the body's immune system attacks its own body. The disease, which literally means "hard skin," can cause a thickening and tightening of the skin. In some cases it causes serious damage to internal organs including the lungs, heart, kidneys, esophagus and gastrointestinal tract. Some medicines and treatments can help with certain symptoms, but there is still no cure for scleroderma, which affects about 300,000 nationwide. (By way of comparison, about 50,000 people have muscular dystrophy, 250,000 are estimated to have lupus and 350,000 have multiple sclerosis.)
Study findings may help shed light on cause of systemic sclerosis

Study findings may help shed light on cause of systemic sclerosis

Infantile spasms and multiple sclerosis relapse data presented at AAN

Infantile spasms and multiple sclerosis relapse data presented at AAN

New research identifies mechanism that may lead to treatment of fibrosis in scleroderma

New research identifies mechanism that may lead to treatment of fibrosis in scleroderma

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Study opens up possibility of developing potential hormone therapies for SSc skin disease

Study opens up possibility of developing potential hormone therapies for SSc skin disease

Implantable loop recorder can help diagnose heart rhythm abnormalities in SSc patients

Implantable loop recorder can help diagnose heart rhythm abnormalities in SSc patients

Nonprofits partner to raise awareness of scleroderma

Nonprofits partner to raise awareness of scleroderma

New BSR report sets roadmap to enhance care for individuals with rare rheumatic and musculoskeletal conditions

New BSR report sets roadmap to enhance care for individuals with rare rheumatic and musculoskeletal conditions

M10 peptide could help protect systemic sclerosis patients against fibrotic damage

M10 peptide could help protect systemic sclerosis patients against fibrotic damage

Complete genetic map of scleroderma opens door for diagnosis and targeted treatment

Complete genetic map of scleroderma opens door for diagnosis and targeted treatment

Systemic sclerosis: an interview with Dr Kristin Highland

Systemic sclerosis: an interview with Dr Kristin Highland

African-American patients with connective tissue diseases at risk for cardiovascular disease

African-American patients with connective tissue diseases at risk for cardiovascular disease

Antiscarring paste can halt fibrosis caused by radiation treatment

Antiscarring paste can halt fibrosis caused by radiation treatment

Stem cell therapy not significantly better than conventional treatment for Crohn's disease

Stem cell therapy not significantly better than conventional treatment for Crohn's disease

Boehringer Ingelheim begins SENSCIS study to investigate safety, efficacy of nintedanib in patients with SSc-ILD

Boehringer Ingelheim begins SENSCIS study to investigate safety, efficacy of nintedanib in patients with SSc-ILD

Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics

Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics

Approval to start trial of Videregen's replacement trachea technology

Approval to start trial of Videregen's replacement trachea technology

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Algorithm reduces PAH screening costs in systemic sclerosis patients

Algorithm reduces PAH screening costs in systemic sclerosis patients

Robert Wood Johnson Medical Group physicians selected for Best Doctors in America List for 2015-2016

Robert Wood Johnson Medical Group physicians selected for Best Doctors in America List for 2015-2016